Smith & Nephew plc
Smith & Nephew plc
SNN
Valuace
65
Růst
85
Zdraví
79
Cena
$ 33.36
Dnes
--0.19 (-0.58%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
14.6B
Obrat
12B
Zisk
1B
Aktiva
11B
Dluh
3B
ROE
15%
ROA
8%
PE
13
PS
1
Cena 1R
24-39
⌀ Cena
32.43
Dividenda
0.2(0.8%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
24-02-2026
Poslední dividenda
03-10-2025

Profil

Společnost Smith & Nephew plc společně s jejími dceřinými společnostmi vyvíjí, vyrábí, prodává a prodává zdravotnické prostředky po celém světě. Společnost nabízí výrobky z kolenních implantátů pro postupy výměny kolenního kloubu; kyčelní implantáty pro rekonstrukci kyčelních kloubů; a traumatologické a končetinové výrobky, které zahrnují vnitřní a vnější zařízení používaná pro stabilizaci těžkých zlomenin a postupů pro korekci deformit. Poskytuje také prostředky pro opravy kloubů sportovní medicíny chirurgům, včetně nástrojů, technologií a implantátů nezbytných k provádění minimálně invazivních operací kloubů, jako je oprava poranění měkkých tkání a degenerativních stavů kolene, kyčle a ramene, stejně jako meniskální opravné systémy. Kromě toho společnost nabízí artroskopické technologie zahrnující zařízení pro řízení tekutin pro chirurgický přístup, kamery s vysokým rozlišením, digitální zachycení obrazu, obory, světelné zdroje a monitory pro pomoc s vizualizací uvnitř kloubů, rádiové frekvence, elektromechanické a mechanické tkáňové resekční zařízení a ruční nástroje pro odstranění poškozené tkáně; a řešení pro uši, nos a hrdlo. Dále poskytuje pokročilé přípravky pro péči o rány pro léčbu a prevenci akutních a chronických ran, které zahrnují nožní, diabetické a tlakové vředy, popáleniny a pooperační rány; pokročilé bioaktivy ran, včetně biologických a jiných bioaktivních technologií pro debridement a dermální reparaci/regeneraci, jakož i regenerativní léčivé přípravky včetně kožních, kostních štěpů a náhražek kloubních chrupavek; a pokročilá zařízení pro rány, jako je tradiční a jednorázová terapie negativních tlakových ran a hydrochirurgické systémy. Slouží především poskytovatelům zdravotní péče. Firma Smith & Nephew plc byla založena v roce 1856 a sídlí ve Watfordu ve Spojeném království.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
17349
Založení
1999-11-16
Adresa
Building 5
CEO
Deepak S. Nath

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues11.996.185.815.555.225.214.565.144.904.774.674.634.624.354.144.273.96
Cost of Revenues3.741.981.761.731.541.541.401.341.301.251.271.141.161.101.071.141.03
Gross Profit8.254.204.053.823.683.673.163.803.613.523.403.493.463.253.073.132.93
Revenue 4-20252-20254-20242-20241-20244-20232-20231-20234-20223-2022
Total Revenues3.192.992.982.831.412.792.731.371.311.31
Cost of Revenues1.100.880.910.850.430.890.840.420.370.37
Gross Profit2.092.112.071.970.991.911.900.950.930.93
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.000.000.000.300.350.360.310.290.250.220.230.220.240.230.170.170.15
Selling General & Admin Expenses0.000.000.002.602.882.722.562.692.502.362.372.642.472.212.052.101.86
Depreciation & Amortization1.150.570.580.530.630.580.600.520.450.460.480.510.440.380.320.310.29
Total Operating Expenses6.593.203.393.393.233.082.872.992.742.582.602.862.712.442.222.272.01
Operating Income1.661.010.660.430.450.590.300.820.860.930.800.630.750.810.850.860.92
Operating Income TTM 4-20252-20254-20242-20241-20244-20232-20231-20234-20223-2022
R&D Expenses0.000.000.000.000.070.170.170.080.130.13
Selling General & Admin Expenses0.000.000.000.000.751.291.420.730.640.64
Depreciation & Amortization0.300.280.390.190.100.380.300.150.070.07
Total Operating Expenses1.521.671.741.650.831.461.58-0.82-0.90-0.90
Operating Income0.570.430.330.330.160.440.320.140.210.21
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income0.090.030.020.030.010.010.010.010.010.010.010.010.010.010.010.000.00
Interest Expense0.250.160.170.140.080.080.060.070.060.060.050.050.040.010.010.010.02
Other Expense-0.38-0.22-0.16-0.14-0.43-0.13-0.19-0.24-0.200.000.15-0.19-0.22-0.090.18-0.01-0.03
IBT1.280.780.500.290.240.590.250.740.780.881.060.560.710.801.100.850.90
Income Tax Expense0.240.150.090.030.010.06-0.200.140.120.110.280.150.210.250.370.270.28
Net Income1.040.630.410.260.220.520.450.600.660.770.780.410.500.560.730.580.62
Net Income TTM 4-20252-20254-20242-20241-20244-20232-20231-20234-20223-2022
Interest Income0.010.020.000.060.030.020.020.000.000.00
Interest Expense0.070.080.090.000.000.080.06-0.02-0.02-0.02
Other Expense-0.15-0.07-0.08-0.07-0.04-0.36-0.04-0.03-0.20-0.20
IBT0.420.370.250.260.130.090.230.110.020.02
Income Tax Expense0.080.070.050.040.02-0.010.040.020.010.01
Net Income0.330.300.200.210.110.090.170.090.020.02
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$0.60$0.50$1.20$1.03$1.37$1.52$1.76$1.76$0.92$1.12$1.23$1.63$1.31$1.39
EPS Diluted$0.00$0.00$0.00$0.60$0.50$1.19$1.02$1.37$1.51$1.75$1.76$0.91$1.11$1.23$1.62$1.30$1.38
Shares Outstanding0.430.430.440.440.450.440.440.440.440.440.440.600.450.450.450.450.44
Diluted Shares Outstanding0.440.440.440.440.450.440.440.440.440.440.450.600.450.450.450.450.44
Per Share Data TTM 4-20252-20254-20242-20241-20244-20232-20231-20234-20223-2022
EPS$0.00$0.00$0.00$0.00$0.12$0.21$0.40$0.10$0.03$0.03
EPS Diluted$0.00$0.00$0.00$0.00$0.12$0.21$0.40$0.10$0.03$0.03
Shares Outstanding0.430.440.440.440.870.440.440.870.880.88
Diluted Shares Outstanding0.440.440.440.440.870.440.440.870.870.87
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents0.570.620.300.351.291.760.280.370.170.100.120.090.140.180.180.21
Short Term Investments0.000.000.000.000.000.000.000.000.000.000.000.000.000.170.000.00
Total Cash & ST Investments0.570.620.300.351.291.760.280.370.170.100.120.090.140.180.180.21
Accounts Receivable1.401.211.06-7.730.000.000.000.000.000.000.000.000.000.000.000.00
Inventory2.492.392.402.211.841.691.611.401.301.241.221.181.010.900.860.92
Other Current Assets0.040.210.279.030.000.000.000.000.000.000.000.000.000.000.000.00
Total Current Assets4.464.424.033.864.424.663.223.082.732.532.482.442.262.142.212.15
Current Assets 2-20254-20242-20241-20244-20232-20231-20234-20223-20222-2022
Cash And Equivalents0.680.620.570.570.300.190.190.350.350.52
Short Term Investments0.000.000.000.000.000.000.000.000.000.00
Total Cash & ST Investments0.680.620.570.570.300.190.190.350.350.52
Accounts Receivable1.481.211.361.361.061.270.00-7.730.000.00
Inventory2.462.392.492.492.402.412.412.212.211.99
Other Current Assets0.000.210.040.040.270.010.009.030.000.00
Total Current Assets4.624.424.464.464.033.883.883.863.863.76
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment1.441.421.471.461.511.451.321.061.050.980.930.890.820.790.780.79
Goodwill3.103.032.993.032.992.932.792.342.372.192.012.031.261.191.101.10
Intangible Assets1.111.031.111.241.401.491.571.211.371.411.501.751.051.060.420.43
Long-Term Investments0.020.020.020.060.200.120.110.140.140.140.130.120.110.120.000.01
Other Long-Term Assets0.080.100.090.150.200.170.140.110.080.000.010.010.180.170.020.03
Total Long-Term Assets6.085.935.966.116.506.356.084.985.144.824.694.873.563.502.542.58
Total Assets10.5410.359.999.9710.9211.019.308.067.877.347.177.315.825.644.754.73
Long-Term Assets 2-20254-20242-20241-20244-20232-20231-20234-20223-20222-2022
Net Property, Plant & Equipment1.431.421.441.441.471.421.421.461.461.46
Goodwill3.113.033.103.102.993.053.053.033.033.02
Intangible Assets0.961.031.111.111.111.181.181.241.241.32
Long-Term Investments0.040.020.020.020.020.040.040.060.060.20
Other Long-Term Assets0.120.100.400.400.090.09-5.690.15-5.780.19
Total Long-Term Assets6.065.936.086.085.965.975.696.115.786.35
Total Assets10.6810.3510.5410.549.999.840.009.970.0010.11
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable1.021.081.021.101.101.021.050.960.960.880.840.840.790.660.560.62
Short-Term Debt0.380.060.770.160.490.340.070.160.030.090.050.040.040.040.310.06
Other Current Liabilities0.150.150.270.691.090.800.620.610.470.540.540.360.320.280.270.04
Current Liabilities1.781.532.271.722.131.691.561.471.351.351.341.161.070.931.140.91
Current Liabilities 2-20254-20242-20241-20244-20232-20231-20234-20223-20222-2022
Accounts Payable1.101.081.021.021.020.960.961.101.031.01
Short-Term Debt0.160.060.380.380.770.410.000.160.000.61
Other Current Liabilities0.290.150.150.370.270.220.810.690.691.10
Current Liabilities1.541.531.781.782.271.771.771.721.722.12
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt3.143.262.322.712.853.351.981.301.421.561.431.670.350.430.020.64
Capital Leases0.130.200.200.200.200.200.170.000.000.010.010.010.010.020.000.00
Def. Tax Liability0.040.000.010.040.140.140.170.100.100.090.080.100.050.060.070.07
Total Liabilities5.345.094.774.715.355.734.163.193.223.393.203.271.771.761.561.96
Long-Term Liabilities 2-20254-20242-20241-20244-20232-20231-20234-20223-20222-2022
Long-Term Debt3.293.263.283.282.322.632.492.712.572.28
Capital Leases0.000.200.180.180.140.190.000.200.000.18
Def. Tax Liability0.040.000.000.000.010.010.000.040.000.11
Total Liabilities5.155.095.345.344.774.614.614.714.714.71
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.180.180.180.180.180.180.180.180.180.180.180.180.180.190.190.19
Retained Earnings4.935.024.915.035.234.964.854.634.333.973.733.653.523.823.262.85
Comprehensive Income-0.440.00-0.390.000.000.000.000.000.000.000.000.000.000.000.000.00
Total Common Equity5.215.275.225.265.575.285.144.874.643.963.974.044.053.883.192.77
Total Common Equity 2-20254-20242-20241-20244-20232-20231-20234-20223-20222-2022
Common Stock0.170.180.180.180.180.180.180.180.180.18
Retained Earnings5.125.024.934.934.914.964.965.035.035.13
Comprehensive Income-0.330.000.00-0.44-0.39-0.410.000.000.000.00
Total Common Equity5.535.275.215.215.225.235.145.265.205.40
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt3.663.323.082.873.343.692.051.471.451.651.481.710.390.470.320.70
Book Value5.215.275.225.265.575.285.144.874.643.963.974.044.053.883.192.77
Other 2-20254-20242-20241-20244-20232-20231-20234-20223-20222-2022
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value5.535.275.215.215.225.235.145.265.205.40
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income0.560.630.410.260.240.590.250.740.780.881.060.560.710.801.100.850.00
Depreciation & Amortization1.020.570.580.530.630.580.600.520.450.460.480.510.440.380.320.310.29
Stock-Based Compensation0.070.000.040.040.040.040.030.030.040.030.030.030.030.030.030.030.02
Change Working Capital-0.490.13-0.12-0.33-0.54-0.150.060.03-0.19-0.10-0.170.07-0.19-0.07-0.02-0.06-0.11
Change In Accounts Receivable-0.09-0.18-0.08-0.05-0.10-0.080.210.03-0.11-0.04-0.07-0.03-0.08-0.07-0.010.000.00
Change In Accounts Payable-0.190.090.00-0.110.000.000.000.000.000.000.000.000.000.000.000.000.00
Change In Inventories-0.500.21-0.04-0.18-0.41-0.15-0.05-0.20-0.15-0.02-0.05-0.08-0.17-0.100.010.040.02
Other Non-cash Items1.14-0.040.080.110.070.070.060.06-0.380.050.050.040.020.000.000.010.66
Cash from Operations0.900.000.000.610.470.880.941.170.931.090.851.030.680.870.900.840.86
Cash Flow From Operating Activities 4-20252-20254-20242-20241-20244-20232-20231-20234-20223-2022
Net Income0.330.300.200.210.110.090.170.090.020.02
Depreciation & Amortization0.300.280.390.190.100.380.300.150.100.10
Stock-Based Compensation0.000.000.020.020.010.020.020.010.010.01
Change Working Capital0.28-0.160.04-0.16-0.080.04-0.370.00-0.26-0.26
Change In Accounts Receivable-0.13-0.05-0.04-0.04-0.02-0.050.000.00-0.05-0.05
Change In Accounts Payable0.20-0.110.000.000.00-0.100.000.000.000.00
Change In Inventories0.210.000.08-0.12-0.06-0.18-0.200.00-0.20-0.20
Other Non-cash Items-0.03-0.010.10-0.03-0.010.740.61-0.190.010.01
Cash from Operations0.000.000.000.000.120.490.110.060.130.13
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-0.68-0.43-0.38-0.43-0.36-0.41-0.44-0.41-0.35-0.38-0.39-0.36-0.38-0.34-0.27-0.32-0.32
Acquisitions-0.210.03-0.19-0.02-0.11-0.29-0.17-0.87-0.03-0.160.01-0.07-1.57-0.07-0.79-0.030.00
Investments0.000.000.000.000.000.000.000.020.00-0.010.000.000.000.000.000.000.00
Sales of Investment0.000.000.000.000.120.290.00-0.020.030.170.050.070.110.000.000.000.00
Other Investing Activities-0.010.000.000.00-0.11-0.280.010.03-0.03-0.17-0.05-0.070.100.000.100.000.01
Cash from Investing-0.900.000.00-0.45-0.47-0.69-0.61-1.25-0.38-0.54-0.38-0.43-1.75-0.41-0.95-0.35-0.31
Cash Flow From Investing Activities 4-20252-20254-20242-20241-20244-20232-20231-20234-20223-2022
Capital Expenditure-0.29-0.14-0.21-0.17-0.09-0.26-0.17-0.08-0.09-0.09
Acquisitions0.030.000.00-0.19-0.09-0.01-0.020.00-0.110.00
Investments0.000.000.000.000.000.000.000.000.020.00
Sales of Investment0.000.000.000.000.000.000.000.000.100.00
Other Investing Activities0.000.000.000.000.000.000.00-0.01-0.01-0.01
Cash from Investing0.000.000.000.00-0.18-0.26-0.18-0.09-0.10-0.10
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-1.290.000.000.18-0.88-0.27-0.41-0.87-0.01-0.15-0.13-0.22-1.30-0.08-0.30-0.39-0.42
Debt Issued8.203.320.240.390.41-0.082.051.450.02-0.050.30-0.012.610.000.440.021.12
Issuance of Common Stock0.000.000.000.000.010.010.010.010.010.010.020.020.040.050.080.020.02
Repurchase of Common Stock-0.03-0.500.000.00-0.16-0.06-0.02-0.06-0.05-0.05-0.37-0.08-0.08-0.230.46-0.01-0.01
Dividends Paid-0.630.000.00-0.33-0.33-0.33-0.33-0.32-0.32-0.27-0.28-0.27-0.25-0.24-0.19-0.15-0.13
Other Financing Activities-0.340.000.00-0.050.430.001.901.24-0.010.020.23-0.022.590.000.000.000.00
Cash from Financing0.130.000.00-0.20-0.93-0.651.160.01-0.37-0.43-0.53-0.561.01-0.500.05-0.52-0.54
Cash Flow From Financing Activities 4-20252-20254-20242-20241-20244-20232-20231-20234-20223-2022
Debt Repaid0.000.000.000.000.000.000.150.00-2.870.00
Debt Issued0.003.453.320.050.523.083.19-2.875.74-2.89
Issuance of Common Stock0.000.000.000.000.000.000.000.00-0.010.00
Repurchase of Common Stock-0.500.000.000.000.000.000.000.00-0.01-0.01
Dividends Paid0.000.000.000.00-0.10-0.12-0.20-0.10-0.06-0.06
Other Financing Activities0.000.000.000.000.290.01-0.030.062.84-0.04
Cash from Financing0.000.000.000.000.19-0.11-0.09-0.04-0.11-0.11
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash0.11-0.060.32-0.04-0.94-0.471.49-0.080.180.12-0.060.04-0.06-0.040.01-0.030.02
Closing Cash Balance0.550.560.620.300.341.291.750.260.330.160.040.100.070.130.170.160.20
Cash position 4-20252-20254-20242-20241-20244-20232-20231-20234-20223-2022
Net Change in Cash-0.120.06-0.550.250.120.11-0.16-0.08-0.08-0.08
Closing Cash Balance0.560.680.000.250.120.300.19-0.080.340.43
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow0.220.850.610.180.110.470.490.760.580.710.460.670.310.530.640.520.54
Real Free Cash Flow0.150.850.570.140.070.430.470.730.550.680.430.640.280.500.600.490.52
Free Cash Flow 4-20252-20254-20242-20241-20244-20232-20231-20234-20223-2022
Free Cash Flow0.590.260.540.070.030.23-0.05-0.030.040.04
Real Free Cash Flow0.590.260.520.050.020.21-0.07-0.040.030.03
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E13.445.4179.3
P/S1.24.8390.6
P/B2.50.2113.4
P/FCF9.868.8149.9
Market cap$14.6$15.0
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets32.3 %13.6 %0 %
Debt to Income332.3 %242.1 %0 %
Debt to Free cash flow243 %62.9 %0 %
Interest expense percentage14.9 %-2.6 %11.2 %
Current ratio3 2.2 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE18.8 %13.3 %0 %
ROA9.7 %5.9 %0 %
CapEx to Revenue5.9 %7.5 %6 %
RaD to Revenue0 %5.3 %0 %
ROEM663,809.8 855351

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin70 %73 %61.9 %
Operating margin12.3 %16.9 %17.9 %
Net margin8 %12.1 %13 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0.8 %1.3 %0 %
Dividend payout percentage191.3 %54.4 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding439.9 mil 706.0 mil
Employee count18.1 tis 12.7 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader